IgA Levels Are Associated with Coronary Artery Lesions in Kawasaki Disease

다국어 초록 (Multilingual Abstract)

Background and Objectives: Kawasaki disease (KD) is an acute systemic vasculitis that affects the coronary arteries. Abnormal immune reactions are thought to contribute to disease pathogenesis. The effect of immunoglobulin (Ig) isotype (IgG, IgA, IgM, and IgE) on inflammatory data and clinical outcomes of patients with KD was examined.
Methods: Ig levels in 241 patients with KD were measured during the acute, subacute, convalescent, and normal phases of the disease.
Results: Compared with reference Ig values, IgG, IgA, and IgM levels were significantly higher in the subacute phase, while IgE levels were elevated in 73.9% (178/241) of patients with KD in all clinical phases. However, high IgE levels were not associated with clinical outcomes, including intravenous immunoglobulin unresponsiveness and coronary artery lesions (CALs). Significantly more CALs were observed in the high IgA group than in the normal IgA group (44.7% vs. 20.8%, respectively; p<0.01). In addition, IgA levels in the acute phase (p=0.038) were 2.2-fold higher, and those in the subacute phase were 1.7-fold higher (p <0.001), in the CAL group than in the non-CAL group. IgA concentrations increased along with the size of the coronary artery aneurysm (p <0.001). Furthermore, there was a strong correlation between IgA levels and CAL size (r=0.435, p<0.001), with a high odds ratio of 2.58 (p=0.022).
Conclusions: High IgA levels in patients with KD are prognostic for the risk of CALs.

참고문헌 (Reference)

1 구청모, "가와사키병과 Immunoglobulin E의 관계" 대한류마티스학회 20 (20): 4-8, 2013

2 Lee YC, "Two new susceptibility loci for Kawasaki disease identified through genome-wide association analysis" 44 : 522-525, 2012

3 Onouchi Y, "The genetics of Kawasaki disease" 21 : 26-30, 2018

4 Liew WK, "The effect of Kawasaki disease on childhood allergies-a sibling control study" 22 : 488-493, 2011

5 Ding Y, "Profiles of responses of immunological factors to different subtypes of Kawasaki disease" 16 : 315-, 2015

6 Purcell S, "PLINK : a tool set for whole-genome association and populationbased linkage analyses" 81 : 559-575, 2007

7 Berndt SI, "Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia" 7 : 10933-, 2016

8 Wood CD, "MYC activation and BCL2L11 silencing by a tumour virus through the large-scale reconfiguration of enhancer-promoter hubs" 5 : e18270-, 2016

9 Lindberg RE, "Levels of IgE in serum from normal children and allergic children as measured by an enzyme immunoassay" 78 : 614-618, 1986

10 Kuo HC, "Kawasaki disease and subsequent risk of allergic diseases : a population-based matched cohort study" 13 : 38-, 2013

11 Bayers S, "Kawasaki disease : part II. Complications and treatment" 69 : 513-, 2013

12 Newburger JW, "Kawasaki disease" 16 : 508-514, 2004

13 Scuccimarri R, "Kawasaki disease" 59 : 425-445, 2012

14 Noval Rivas M, "Intestinal permeability and IgA provoke immune vasculitis linked to cardiovascular inflammation" 51 : 508-521, 2019

15 Wei CC, "Increased risk of Kawasaki disease in children with common allergic diseases" 24 : 340-343, 2014

16 Yanagimoto K, "Immunoglobulin G values before treatment are correlated with the responsiveness to initial intravenous immunoglobulin therapy for Kawasaki disease" 164 : 83-88, 2014

17 Rowley AH, "IgA plasma cells in vascular tissue of patients with Kawasaki syndrome" 159 : 5946-5955, 1997

18 Rowley AH, "IgA plasma cell infiltration of proximal respiratory tract, pancreas, kidney, and coronary artery in acute Kawasaki disease" 182 : 1183-1191, 2000

19 Jonsson S, "Identification of sequence variants influencing immunoglobulin levels" 49 : 1182-1191, 2017

20 Gregory GA, "Gregory's Pediatric Anesthesia" Blackwell Publishing Ltd 1300-1314, 2012

21 Khor CC, "Genome-wide association study identifies FCGR2A as a susceptibility locus for Kawasaki disease" 43 : 1241-1246, 2011

22 Farh KK, "Genetic and epigenetic fine mapping of causal autoimmune disease variants" 518 : 337-343, 2015

23 Kusakawa S, "Elevated levels of immunoglobulin E in the acute febrile mucocutaneous lymph node syndrome" 10 : 108-111, 1976

24 Newburger JW, "Diagnosis, treatment, and long-term management of Kawasaki disease : a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association" 110 : 2747-2771, 2004

25 Sawaji Y, "Coronary risk factors in acute Kawasaki disease : correlation of serum immunoglobulin levels with coronary complications" 40 : 218-225, 1998

26 Kwon YC, "BCL2L11 is associated with Kawasaki disease in intravenous immunoglobulin responder patients" 11 : e002020-, 2018

27 Kawasaki T, "Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children" 16 : 178-222, 1967

28 Onouchi Y, "A genome-wide association study identifies three new risk loci for Kawasaki disease" 44 : 517-521, 2012

29 Kim JJ, "A genome-wide association analysis identifies NMNAT2 and HCP5 as susceptibility loci for Kawasaki disease" 62 : 1023-1029, 2017